Humasis Co. Ltd. (KOSDAQ:205470)
2,665.00
-10.00 (-0.37%)
Jun 11, 2026, 3:00 PM KST
Nations Trust Bank Market Cap
Humasis has a market cap or net worth of 60.54 billion as of June 10, 2026. Its market cap has decreased by -61.92% in one year.
Market Cap
60.54B
Enterprise Value
-101.11B
Revenue
32.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,665.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 60.54B, an increase of 462.44%. That is a compound annual growth rate of 21.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 63.93B | -44.28% |
| Dec 30, 2025 | 114.74B | -38.06% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 57.54T |
| Celltrion | 35.08T |
| ALTEOGEN | 15.49T |
| Samsung Epis Holdings | 10.09T |
| PharmGen Science | 67.95B |
| LabGenomics | 66.07B |
| BIT Computer | 62.81B |
| Yuyu Pharma | 60.16B |